Estimating Typical Multiple Sclerosis Disability Progression Speed from Clinical Observations

Evaluating the Potential Benefit of Interferon Treatment in Multiple Sclerosis

(2012) Tobias Derfuss et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

New perspectives in the natural history of multiple sclerosis

(2010) H. Tremlett et al.   NEUROLOGY

How Spacing of Data Collection May Impact Estimates of Substance Use Trajectories

(2010) Xianming Tan et al.   SUBSTANCE USE & MISUSE

The history of multiple sclerosis: the changing frame of the disease over the centuries

(2009) T. Jock Murray   JOURNAL OF THE NEUROLOGICAL SCIENCES

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation

(2009) PJ Veugelers et al.   Multiple Sclerosis Journal

Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease

(2008) L Costelloe et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway

(2008) N Grytten Torkildsen et al.   Multiple Sclerosis Journal

Defining the natural history of MS: the need for complete data and rigorous definitions

(2008) Helen Tremlett et al.   Multiple Sclerosis Journal

Progression in familial and nonfamilial MS

(2008) Marcus Koch et al.   Multiple Sclerosis Journal

Historical and Clinical Perspectives of the Expanded Disability Status Scale

(2008) John F. Kurtzke   NEUROEPIDEMIOLOGY